PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Manus Bio receives additional funding to combat malaria

The fourth award from the Bill & Melinda Gates Foundation will support artemisinin research. Manus Bio – the leading biomanufacturer of natural products – has...
Continue Reading →
News

Trilogy Writing & Consulting gains PIF TICK accreditation to be recognised as a ‘trusted information creator’

Trilogy Writing & Consulting has been awarded the PIF TICK – the UK’s only assessed quality mark for print and online health and care information. To be award...
Continue Reading →
News

European Commission approves pharma trio’s Ranivisio

Therapy is a biosimilar of Lucentis which treats several serious retinal diseases across the European Union. The European Commission (EC) has granted marketing au...
Continue Reading →
News

Novartis’ Scemblix approved by the EC for adults with chronic myeloid leukaemia

It is estimated that every year more than 6,300 people will be diagnosed with CML in Europe. Novartis has announced that the European Commission (EC) has approved...
Continue Reading →
News

MIT’s AI model can detect Parkinson’s by tracking breathing patterns

A team of researchers from the Massachusetts Institute of Technology (MIT), in collaboration with the University of Rochester, Mayo Clinic and Massachusetts General ...
Continue Reading →
News

Neurocrine Biosciences to buy Diurnal

California-based neurology specialist Neurocrine Biosciences will acquire Diurnal in a cash deal that values the UK biotech at close to $57 million. ...
Continue Reading →
News

ACG to Launch German Process Laboratory in 2023

Following the success of its first-to-market laboratory for process development in India, ACG (the world's biggest integrated pharmaceutical and nutraceutical manufa...
Continue Reading →
News

SHORTLIST ANNOUNCED FOR INAUGURAL SUSTAINABLE MEDICINES PACKAGING AWARDS

Finalists showcase innovations in sustainable pharmaceutical packaging, with winners to be announced at Connect in Pharma 25 August 2022 / Sciad Newswire / Ye...
Continue Reading →
News

EMA accepts application for leukaemia drug from Otsuka and Astex

The European Medicines Agency (EMA) has accepted Otsuka Pharmaceutical and Astex Pharmaceuticals’ marketing authorisation application (MAA) for an oral fixed-dose co...
Continue Reading →
News

New study use musical tests for early detection of cognitive decline

Researchers at Tel Aviv University have created a method which uses musical tests and a portable brain activity-measuring device to detect cognitive decline in older...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026